Elif Aras-Atik

5PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 01, 2025
Medication regimen complexity in cancer patients: an overlooked issue for healthcare team.

Sude Ayca Cifci, Elif Aras Atik, Ömer Dizdar

|Apr 06, 2022
International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions.

Andrew Walker, Alexandre Chan, Constanza Cortés Labra

|May 24, 2021
International Society of Oncology Pharmacy Practitioners (ISOPP) position statement: Role of the oncology pharmacy team in cancer care.

Lisa M Holle, Tegan Bilse, Ramatu Masud Alabelewe

|Jan 04, 2021
Can Alpha-1 Antitrypsin Levels be Used to Predict the Prognosis of COVID-19 Therapy?

Elif Aras Atik, Nesligül Özdemir, Kutay Demirkan

|Jul 07, 2020
Are we aware of potential interactions between drugs used in lung cancer and drugs used in the treatment of COVID-19?

Elif Aras-Atik, Kamer Tecen-Yucel, Aygin Bayraktar-Ekincioglu

Pageof 1

Frequent Collaborators

3 joint publications

Aygin Bayraktar-Ekincioglu

2 joint publications

Esin Aysel Kandemir

2 joint publications

Karunrat Tewthanom

1 joint publications

Nesligül Özdemir